Regulus Therapeutics Inc. Annual Return On Assets in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Regulus Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from 2013 to 2023.
  • Regulus Therapeutics Inc. Return On Assets for the quarter ending June 30, 2024 was -49.4 %, a 22.3% increase year-over-year.
  • Regulus Therapeutics Inc. annual Return On Assets for 2023 was -80.6 %, a 52.2% decline from 2022.
  • Regulus Therapeutics Inc. annual Return On Assets for 2022 was -52.9 %, a 4.46% increase from 2021.
  • Regulus Therapeutics Inc. annual Return On Assets for 2021 was -55.4 %, a 14.2% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -80.6 -27.6 -52.2% Jan 1, 2023 Dec 31, 2023
2022 -52.9 +2.47 +4.46% Jan 1, 2022 Dec 31, 2022
2021 -55.4 -6.88 -14.2% Jan 1, 2021 Dec 31, 2021
2020 -48.5 +19.7 +28.9% Jan 1, 2020 Dec 31, 2020
2019 -68.2 +43.8 +39.1% Jan 1, 2019 Dec 31, 2019
2018 -112 -19.4 -21% Jan 1, 2018 Dec 31, 2018
2017 -92.6 -23.7 -34.3% Jan 1, 2017 Dec 31, 2017
2016 -68.9 -31.7 -85.3% Jan 1, 2016 Dec 31, 2016
2015 -37.2 +6.96 +15.8% Jan 1, 2015 Dec 31, 2015
2014 -44.2 -27.3 -162% Jan 1, 2014 Dec 31, 2014
2013 -16.9 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.